These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3051029)

  • 21. Comments on license requirements and veterinary biologicals.
    Baker LR
    J Am Vet Med Assoc; 1972 Feb; 160(4):509-10. PubMed ID: 5030605
    [No Abstract]   [Full Text] [Related]  

  • 22. [Recent aspects of the microbiological contamination of pharmaceutical products and their microbiological specification (author's transl)].
    Kurata H; Ishizeki C; Udagawa S
    Eisei Shikenjo Hokoku; 1978; (96):1-26. PubMed ID: 373832
    [No Abstract]   [Full Text] [Related]  

  • 23. Multi-use manufacturing facilities.
    Garfinkle BD
    Dev Biol Stand; 1996; 88():131. PubMed ID: 9119124
    [No Abstract]   [Full Text] [Related]  

  • 24. Guidance for temperature-controlled medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment.
    Parenteral Drug Association
    PDA J Pharm Sci Technol; 2007; 61(2 Suppl TR 39):2-19. PubMed ID: 17953229
    [No Abstract]   [Full Text] [Related]  

  • 25. [The economics of therapeutic investigations (author's transl)].
    Poisvert M
    Anesth Analg (Paris); 1980; 37(9-10):619-20, 623-6. PubMed ID: 7469079
    [No Abstract]   [Full Text] [Related]  

  • 26. "Studies on biodiversity of Vietnam and Laos" 1998-2005: examining the impact.
    Soejarto DD; Zhang HJ; Fong HH; Tan GT; Ma CY; Gyllenhaal C; Riley MC; Kadushin MR; Franzblau SG; Bich TQ; Cuong NM; Hiep NT; Loc PK; Xuan le T; Hai NV; Hung NV; Chien NQ; Binh le T; Vu BM; Ly HM; Southavong B; Sydara K; Bouamanivong S; Pezzuto JM; Rose WC; Dietzman GR; Miller BE; Thuy TV
    J Nat Prod; 2006 Mar; 69(3):473-81. PubMed ID: 16562860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural products to drugs: natural product derived compounds in clinical trials.
    Butler MS
    Nat Prod Rep; 2005 Apr; 22(2):162-95. PubMed ID: 15806196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmaceutical products and standards of good production].
    Lubner GC
    Boll Chim Farm; 1975 Jan; 114(1):10-20. PubMed ID: 1203094
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental product testing of biomedicines].
    Vieths S; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1131-2. PubMed ID: 25200486
    [No Abstract]   [Full Text] [Related]  

  • 30. Non-clinical local tolerance testing of medicinal products. CPMP Working Party on Safety of Medicinal Products.
    Pharmacol Toxicol; 1991 Mar; 68(3):233-6. PubMed ID: 2057456
    [No Abstract]   [Full Text] [Related]  

  • 31. Draft guideline on detection of toxicity to reproduction for medicinal products.
    Bass R; Ulbrich B; Hildebrandt AG; Weissinger J; Doi O; Baeder C; Fumero S; Harada Y; Lehmann H; Manson J
    Adverse Drug React Toxicol Rev; 1991; 10(3):127-41. PubMed ID: 1747440
    [No Abstract]   [Full Text] [Related]  

  • 32. Natural products as a screening resource.
    Harvey AL
    Curr Opin Chem Biol; 2007 Oct; 11(5):480-4. PubMed ID: 17884696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plant natural products: back to the future or into extinction?
    McChesney JD; Venkataraman SK; Henri JT
    Phytochemistry; 2007 Jul; 68(14):2015-22. PubMed ID: 17574638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seventh WHO informal consultation on standards for cytokines, growth factors and endocrinological substances.
    Meager A
    Biologicals; 2004 Jun; 32(2):105-11. PubMed ID: 15454189
    [No Abstract]   [Full Text] [Related]  

  • 36. Marine natural products and related compounds in clinical and advanced preclinical trials.
    Newman DJ; Cragg GM
    J Nat Prod; 2004 Aug; 67(8):1216-38. PubMed ID: 15332835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The need for international surveillance of biologicals: distribution, use, and efficacy.
    Halter S; LaFontaine A
    Bull World Health Organ; 1977; 55 Suppl 2(Suppl 2):157-61. PubMed ID: 305308
    [No Abstract]   [Full Text] [Related]  

  • 38. Biologicals: new horizons in pharmaceutical development.
    Oldham RK
    J Biol Response Mod; 1983; 2(3):199-206. PubMed ID: 6358418
    [No Abstract]   [Full Text] [Related]  

  • 39. A prototypical process for creating evidentiary standards for biomarkers and diagnostics.
    Altar CA; Amakye D; Bounos D; Bloom J; Clack G; Dean R; Devanarayan V; Fu D; Furlong S; Hinman L; Girman C; Lathia C; Lesko L; Madani S; Mayne J; Meyer J; Raunig D; Sager P; Williams SA; Wong P; Zerba K
    Clin Pharmacol Ther; 2008 Feb; 83(2):368-71. PubMed ID: 18091762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Laboratory for the control of serum vaccines and other biological products].
    M'Henni A
    Arch Inst Pasteur Tunis; 1997; 74(1-2):129-33. PubMed ID: 15945193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.